Korean J Intern Med.  2019 Sep;34(5):1091-1099. 10.3904/kjim.2018.139.

Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy

Affiliations
  • 1Division of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 2Division of Nephrology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea.
  • 3Division of Nephrology, Department of Internal Medicine, College of Medicine, Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Korea.
  • 4Division of Nephrology, Department of Internal Medicine, College of Medicine, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon, Korea.
  • 5Division of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea. hwanghs@catholic.ac.kr

Abstract

BACKGROUND/AIMS
Membranous nephropathy (MN) is the most common primary glomerular disease diagnosed in older patients. Few reports describe the clinical outcomes in older patients with idiopathic MN.
METHODS
The outcomes of 135 patients with histologically proven MN were analyzed. "˜Older' was defined as 60 years of age or older at the time of the renal biopsy. The rates of complete remission (CR), progression to end-stage renal disease (ESRD) and infection were compared between older and younger patients.
RESULTS
The cumulative event rate for achieving CR was inferior (p = 0.012) and that for requiring renal replacement was higher (p = 0.015) in older patients, and they had a greater risk of infection (p = 0.005). Older age was a significant predictor of a lower rate of CR (adjusted odds ratio [OR], 0.51; 95% confidence interval [CI], 0.26 to 0.98), and was a robust predictor of infection (adjusted OR, 5.27; 95% CI, 1.31 to 21.20). Conservative treatment was associated with a lower remission rate (p = 0.036) and corticosteroid treatment was less effective in achieving CR (p = 0.014), in preventing progression to ESRD (p = 0.013) and in reducing infection (p = 0.033) in older patients. Cyclosporine treatment had similar clinical outcomes with regard to CR, ESRD progression, and infection in older patients.
CONCLUSIONS
Older age was independently associated with inferior rates of CR and greater risk of infection. Treatment modalities affected the outcomes of older patients differently in that cyclosporine treatment is predicted to be more useful than corticosteroids.

Keyword

Aged; Glomerulonephritis, membranous; Prognosis

MeSH Terms

Adrenal Cortex Hormones
Biopsy
Cyclosporine
Glomerulonephritis, Membranous*
Humans
Kidney Failure, Chronic
Odds Ratio
Prognosis
Adrenal Cortex Hormones
Cyclosporine
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr